Nanocurcumin restores aberrant miRNA expression profile in multiple sclerosis, randomized, double‐blind, placebo‐controlled trial

Author:

Dolati Sanam123,Aghebati‐Maleki Leili45,Ahmadi Majid25,Marofi Faroogh5,Babaloo Zohreh5,Ayramloo Hormoz6,Jafarisavari Zahra1,Oskouei Hamid1,Afkham Amir5,Younesi Vahid7,Nouri Mohammad1,Yousefi Mehdi25ORCID

Affiliation:

1. Stem Cell and Regenerative Medicine InstituteTabriz University of Medical SciencesTabrizIran

2. Drug Applied Research CenterTabriz University of Medical SciencesTabrizIran

3. Student's Research CommitteeTabriz University of Medical SciencesTabrizIran

4. Immunology Research CenterTabriz University of Medical SciencesTabrizIran

5. Faculty of MedicineDepartment of ImmunologyTabriz University of Medical SciencesTabrizIran

6. Faculty of MedicineDepartments of NeurologyTabriz University of Medical SciencesTabrizIran

7. Pishtaz Teb DiagnosticsTehranIran

Funder

Tabriz University of Medical Sciences

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Cited by 70 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3